North America vision care market is projected to register a CAGR of 9.8% from 2016 to 2026 and is expected to be valued at US$ 100.72 Bn by the end of 2026 Future Market Insights delivers key insights on the North America vision care market in a new publication titled “Vision Care Market: North America Industry Analysis …
Author Archives: Editor AN
Prosthetic Heart Valve Market totalling US$ 36.3 Billion by 2032 | FMI
According to Future Market Insights, an increasing prevalence of valvular heart disease (VHD) is expected to augment growth of the global prosthetic heart valve market during the forecast period. Regulatory approval for heart valves, integration of technological advancements, and increasing number of heart valve implantation procedures are other factors expected to influence revenue growth of the global …
Continue reading “Prosthetic Heart Valve Market totalling US$ 36.3 Billion by 2032 | FMI”
Ever Rising Cases of Cardiovascular Diseases (CVDs) Drive the Coronary Stents Market to Reach a Revenue of US$ 51.2 Mn During the Forecast Period of 2022-32 | Future Market Insights, Inc.
According to the most recent Future Market Insights (FMI) report, the demand for portable and coronary stents market will increase significantly over the next few years. The demand for interventional cardiology care is being fuelled by the rising prevalence of coronary artery disease. Angioplasty is the first choice of treatment for patients with long-term CAD. Over the …
Continuous Glucose Monitoring Systems Market Demand for continuous glucose monitoring systems in Europe is expected to register a growth of 10.2% CAGR from 2022 to 2032
[Report of 261 Pages] The market for continuous glucose monitoring systems is anticipated to reach a valuation of US$ 1.1 billion in 2022 and then grow at a CAGR of 10.8% to US$ 3.0 billion by the end of 2032. In 2021, the global continuous glucose monitoring systems market will be dominated by sensors, with a share …
With Diabetic Population exploding, the global Insulin Biosimilars Market to reach US$ 5.88 Bn by the year 2032 at a robust CAGR of 21.5% in the forecast period 2022 to 32
The global insulin biosimilars market is worth US$ 1.47 Bn as of now and expected to reach US$ 5.88 Bn by the year 2032 at a stellar CAGR of 21.5% between 2022 and 2032. Biosimilar insulin has the capacity of reducing treatment costs of diabetes, increasing insulin treatment’s accessibility, and expanding number of various insulin …
Surgical Sutures Market to Garner US$ 13.9 Bn by the year 2032 Attributed to Their Extensive Application in the Healthcare Industry
The global surgical sutures market is expanded at a healthy CAGR of 5.4% across the projection period from 2022 to 2032. The market is expected to enjoy a valuation of around US$ 8.2 Bn by the end of the year 2022 and further reach an estimation of around US$ 13.9 Bn by the year 2032. …
Pap Tests to Contribute the Most to HPV Testing and Pap Test Market throughout the Analysis Period, States Future Market Insights
The Global HPV testing and Pap Test Market was valued at US$ 2.2 Bn in 2021 and is expected to reach US$ 15 Bn by 2032, finds Future Market Insights (FMI) in a recent market survey. As per the findings of the report, Pap Testing will remain pivotal for the market as the bulk of …
Increasing Demand for Healthcare Sector and Need for Robust Security Led to a Surge in Medical Terahertz Technology Sales | FMI Taps a Market Valuation of US$ 135.29 Mn in 2022
According to a report published by FMI, the global medical terahertz technology market will be valued at US$ 135.29 Mn in 2022. It is expected to grow at a CAGR of 17.1% during the forecast period, reaching a value of US$ 768.05 Mn by 2032. A fast-growing field of terahertz technology is driving market growth …
Ferric Carboxymaltose to Generate nearly 50% of the Intravenous Iron Drugs Market throughout the Analysis Period, according to Future Market Insights
Global Intravenous Iron Drugs Market was valued at US$ 2.6 Bn in 2021 and is expected to reach US$ 6.3 Bn by 2032, finds FMI in a recent market survey. As per the findings of the report, Intravenous Iron Drugs revenue through Ferric Carboxymaltose will garner significant demand in the market as the bulk of …
Medical Biomimetics Market Valuation surpass US$ 63 Billion by 2032; Cardiovascular Biomimetics to comprise 43% Revenue | FMI Report
During the forecast period 2023-2033, the medical biomimetics market is expected to grow at a value of 7% CAGR, according to Future Market Insights. By the year 2033, the global market for medical biomimetics is expected to rise up to a market valuation of US$ 63.15 Billion. Growing advancement in nanotechnology, increasing demand for prostheses …